Den europeiske union - tsjekkisk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vakcíny - infanrix hexa je určen pro základní očkování a přeočkování dětí proti záškrtu, tetanus, černý kašel, hepatitida b, poliomyelitida a onemocnění způsobených haemophilus influenzae typu b.

Slovenia - slovensk - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsk d.o.o., ljubljana - davični toksoid; hemaglutinin, filamentozni; tetanusni toksoid; toksoid b. pertussis; poliovirus tipa 1 (sev mahoney), inaktivirani; poliovirus tipa 2 (sev mef-1), inaktivirani; poliovirus tipa 3 (sev saukett), inaktivirani; polisaharid hemofilusa tipa b; pertaktin - prašek in suspenzija za suspenzijo za injiciranje - davični toksoid 30 i.e. / 0,5 ml  hemaglutinin, filamentozni25 i.e. / 0,5 ml  tetanusni toksoid40 i.e. / 0,5 ml  toksoid b. pertussis25 i.e. / 0,5 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 0,5 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml  pertaktin8 i.e. / 0,5 ml; hemaglutinin, filamentozni 25 i.e. / 0,5 ml  tetanusni toksoid40 i.e. / 0,5 ml  toksoid b. pertussis25 i.e. / 0,5 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 0,5 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml  pertaktin8 i.e. / 0,5 ml; tetanusni toksoid 40 i.e. / 0,5 ml  toksoid b. pertussis25 i.e. / 0,5 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 0,5 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml  pertaktin8 i.e. / 0,5 ml; toksoid b. pertussis 25 i.e. / 0,5 ml  poliovirus tipa 1 (sev mahoney), inaktivirani40 i.e. / 0,5 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml  pertaktin8 i.e. / 0,5 ml; poliovirus tipa 1 (sev mahoney), inaktivirani 40 i.e. / 0,5 ml  poliovirus tipa 2 (sev mef-1), inaktivirani8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml  pertaktin8 i.e. / 0,5 ml; poliovirus tipa 2 (sev mef-1), inaktivirani 8 i.e. / 0,5 ml  poliovirus tipa 3 (sev saukett), inaktivirani32 i.e. / 0,5 ml  polisaharid hemofilusa tipa b10 i.e. / 0,5 ml &n - mešano cepivo proti davici, hemofilusu influence, oslovskemu kašlju, otroški paralizi in tetanusu

Den europeiske union - slovensk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - cepiva - infanrix hexa je indicirano za osnovno in obnovitveno cepljenje dojenčkov proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in bolezen, ki povzroča haemophilus influenzae tipa b.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; tetanus toxoid, quantity: 80 iu/ml; pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; poliovirus, quantity: 80 dagu; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 60 iu/ml; pertactin, quantity: 16 microgram/ml; poliovirus, quantity: 16 dagu; poliovirus, quantity: 64 dagu - injection, suspension - excipient ingredients: aluminium phosphate; sodium chloride; aluminium hydroxide hydrate; neomycin sulfate; polymyxin b sulfate; water for injections; glucose monohydrate; polysorbate 80; ascorbic acid; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inosit - infanrix hexa is indicated for primary immunisation of infants from the age of 6 weeks against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis, and haemophilus influenzae type b. infanrix hexa is also indicated for use as booster dose if boosting with hepatitis b, poliomyelitis, and haemophilus influenzae type b, as well as diphtheria, tetanus and pertussis is required. refer to dosage and administration for further information.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; pertactin, quantity: 16 microgram/ml; tetanus toxoid, quantity: 80 iu/ml; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 60 iu/ml - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; sodium chloride - infanrix is indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole-cell) vaccine. indications as of 8th january 1997 - infanrix (dtpa) is indicated for active primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. infanrix (dtpa) is also indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria,tetanus and pertussis (whole-cell or acellular) vaccine.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; pertactin, quantity: 16 microgram/ml; pertussis toxoid, quantity: 50 microgram/ml; tetanus toxoid, quantity: 20 lfu/ml; diphtheria toxoid, quantity: 50 lfu/ml - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; sodium chloride - infanrix is indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria, tetanus and pertussis (whole-cell) vaccine. indications as of 8th january 1997 - infanrix (dtpa) is indicated for active primary immunisation against diphtheria, tetanus and pertussis when commenced between 2 months and 12 months of age. infanrix (dtpa) is also indicated as fourth and fifth dose for children from 15 months of age up to and including 6 years of age who have been immunised previously with three or four doses of diphtheria,tetanus and pertussis (whole-cell or acellular) vaccine.

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - Ваксини - infanrix хекса е показан за първичен и помощник ваксинация на децата срещу дифтерия, тетанус, коклюш, хепатит Б, полиомиелит и заболявания, причинени от haemophilus инфлуенца тип-б.

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)), hepatitis b surface antigen - hepatitis b; tetanus; immunization; whooping cough; poliomyelitis; diphtheria - Ваксини - infanrix penta е показан за първична и бустер ваксинация на кърмачета срещу дифтерия, тетанус, коклюш, хепатит В и полиомиелит.

Den europeiske union - maltesisk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis b surface antigen, poliovirus (inactivated) (type-1 (mahoney strain), type-2 (mef-1 strain), type-3 (saukett strain)), haemophilus influenzae type b polysaccharide - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaċċini - infanrix hexa huwa indikat għall-vaċċinazzjoni primarja u booster tat-trabi kontra diphtheria, tetanus, pertussis, epatite b, poliomyelitis u mard ikkawżat minn influwenza Ħemofillika tip-b.

Den europeiske union - maltesisk - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (mahoney strain), type 2 (mef-1 strain), type 3 (saukett strain)), hepatitis b surface antigen - hepatitis b; tetanus; immunization; whooping cough; poliomyelitis; diphtheria - vaċċini - infanrix penta huwa indikat għall-vaċċinazzjoni primarja u booster tat-trabi kontra diphtheria, tetanus, pertussis, epatite b u poliomyelitis.